Prospective, Registry-Based Observational Cohort Study of Ritlecitinib Safety in Pregnancy

Data sources

• Data source(s), other:
  This will be a new, product-based pregnancy registry conducted by PPD (part of Thermo Fisher Scientific).
• Data sources (types):
  Pregnancy registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown